CR MEDICAL (01515) issued a profit warning, anticipating that the annual profit attributable to shareholders in 2025 will be approximately 4.67 billion to 5.16 billion yuan, a year-on-year decrease of about 17.5% to 8.9%.

CR MEDICAL (01515) announced that the company's attributable profit for the year ending December 31, 2025 is expected to be approximately RMB 4.67 billion to RMB 5.16 billion. This represents a decrease of approximately 17.5% to 8.9% compared to the attributable profit for the year ending December 31, 2024 (2024 fiscal year) of approximately RMB 5.66 billion. Excluding the one-time receipt of approximately RMB 2.1 billion under the Yanhua IOT agreement for previous years' management fees and supply chain loss compensation, and the corresponding corporate income tax, the attributable profit of the company is expected to decrease by approximately 43.5% to 37.6% compared to the 2024 fiscal year. This decrease is narrower by approximately 13.9 to 19.8 percentage points compared to a 57.4% decrease in attributable profit for the first half of 2025 (excluding Yanhua case compensation) compared to the same period in 2024. The decrease in attributable profit during the reporting period is mainly attributed to a decrease in the average medical insurance cost per member leading to a decline in operational profit for member medical institutions, as well as the reduction in scale of the company's IOT (investment-operation-transfer) business.